146 related articles for article (PubMed ID: 8551261)
1. Serial quantitation of HPV-16 in the smears of women with mild and moderate dyskaryosis.
Flannelly G; Jiang G; Anderson D; Melvin W; Mann E; Kitchener H
J Med Virol; 1995 Sep; 47(1):6-9. PubMed ID: 8551261
[TBL] [Abstract][Full Text] [Related]
2. High-risk HPV testing in women with borderline and mild dyskaryosis: long-term follow-up data and clinical relevance.
Denise Zielinski G; Snijders PJ; Rozendaal L; Voorhorst FJ; Runsink AP; de Schipper FA; Meijer CJ
J Pathol; 2001 Oct; 195(3):300-6. PubMed ID: 11673826
[TBL] [Abstract][Full Text] [Related]
3. HPV testing in primary screening of older women.
Cuzick J; Beverley E; Ho L; Terry G; Sapper H; Mielzynska I; Lorincz A; Chan WK; Krausz T; Soutter P
Br J Cancer; 1999 Oct; 81(3):554-8. PubMed ID: 10507785
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus type 16 and 18 detection in the management of mild dyskaryosis.
Cruickshank ME; Buchan S; Melvin WT; Kitchener HC
Br J Obstet Gynaecol; 1999 Sep; 106(9):969-76. PubMed ID: 10492111
[TBL] [Abstract][Full Text] [Related]
5. Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation.
Verguts J; Bronselaer B; Donders G; Arbyn M; Van Eldere J; Drijkoningen M; Poppe W
BJOG; 2006 Nov; 113(11):1303-7. PubMed ID: 16978225
[TBL] [Abstract][Full Text] [Related]
6. The role of human papillomavirus testing in the management of women with low-grade abnormalities: multicentre randomised controlled trial.
Cotton S; Sharp L; Little J; Cruickshank M; Seth R; Smart L; Duncan I; Harrild K; Neal K; Waugh N;
BJOG; 2010 May; 117(6):645-59. PubMed ID: 20374607
[TBL] [Abstract][Full Text] [Related]
7. PCR-based high-risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologically normal cervical smears.
Rozendaal L; Walboomers JM; van der Linden JC; Voorhorst FJ; Kenemans P; Helmerhorst TJ; van Ballegooijen M; Meijer CJ
Int J Cancer; 1996 Dec; 68(6):766-9. PubMed ID: 8980181
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus status in the prediction of high-grade cervical intraepithelial neoplasia in patients with persistent low-grade cervical cytological abnormalities.
Herrington CS; Evans MF; Hallam NF; Charnock FM; Gray W; McGee JD
Br J Cancer; 1995 Jan; 71(1):206-9. PubMed ID: 7819041
[TBL] [Abstract][Full Text] [Related]
9. Persistent human papillomavirus infection and smoking increase risk of failure of treatment of cervical intraepithelial neoplasia (CIN).
Acladious NN; Sutton C; Mandal D; Hopkins R; Zaklama M; Kitchener H
Int J Cancer; 2002 Mar; 98(3):435-9. PubMed ID: 11920596
[TBL] [Abstract][Full Text] [Related]
10. Value of HPV-DNA test in women with cytological diagnosis of atypical glandular cells (AGC).
Zeferino LC; Rabelo-Santos SH; Villa LL; Sarian LO; Costa MC; do Amaral Westin MC; de Ângelo-Andrade LA; Derchain S
Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):160-4. PubMed ID: 21680079
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus DNA status after loop excision for cervical intraepithelial neoplasia grade III - A prospective study.
Nagai N; Mukai K; Oshita T; Shiroyama Y; Ohama K
Int J Mol Med; 2004 Apr; 13(4):589-93. PubMed ID: 15010861
[TBL] [Abstract][Full Text] [Related]
12. Expanded cytological referral criteria for colposcopy in cervical screening: comparison with human papillomavirus testing.
Paraskevaidis E; Malamou-Mitsi V; Koliopoulos G; Pappa L; Lolis E; Georgiou I; Agnantis NJ
Gynecol Oncol; 2001 Aug; 82(2):355-9. PubMed ID: 11531293
[TBL] [Abstract][Full Text] [Related]
13. Are benign cellular changes on a Papanicolaou smear really benign? A prospective cohort study.
Margolis KL; Carson LF; Setness PA; Stanley MW; Henry-Stanley MJ; Beneke J; Linzie B; McGlennen RC
Arch Fam Med; 1999; 8(5):433-9. PubMed ID: 10500518
[TBL] [Abstract][Full Text] [Related]
14. Prospective study on cervical neoplasia: presence of HPV DNA in cytological smears precedes the development of cervical neoplastic lesions.
Tachezy R; Saláková M; Hamsíková E; Kanka J; Havránková A; Vonka V
Sex Transm Infect; 2003 Jun; 79(3):191-6. PubMed ID: 12794200
[TBL] [Abstract][Full Text] [Related]
15. [Combining high-risk human papillomavirus DNA test and cytological test to detect early cervical dysplasia].
Qian DY; Cen JM; Wang D; Zeng RH; Lin AH; Shu YH; Hong DH; Huang ZH
Zhonghua Fu Chan Ke Za Zhi; 2006 Jan; 41(1):34-7. PubMed ID: 16635326
[TBL] [Abstract][Full Text] [Related]
16. Managing atypical squamous cells of undetermined significance in Papanicolaou smears.
Morin C; Bairati I; Bouchard C; Fortier M; Roy M; Moore L; Meisels A
J Reprod Med; 2001 Sep; 46(9):799-805. PubMed ID: 11584480
[TBL] [Abstract][Full Text] [Related]
17. The clinical value of digene hybrid capture HPV DNA testing in a referral-based population with abnormal pap smears.
Recio FO; Sahai Srivastava BI; Wong C; Hempling RE; Eltabbakh GH; Piver MS
Eur J Gynaecol Oncol; 1998; 19(3):203-8. PubMed ID: 9641214
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of variable methods for HPV testing].
Cheng JY; Bian ML; Ma L; Cong X; Chen Y; Liu J
Zhonghua Fu Chan Ke Za Zhi; 2013 Aug; 48(8):589-94. PubMed ID: 24199924
[TBL] [Abstract][Full Text] [Related]
19. Cytological evaluation and molecular human papillomavirus test of cervical scrapings from women treated for condyloma.
Zehbe I; Strand A; Chua KL; Wilander E
Gynecol Obstet Invest; 1996; 42(2):128-32. PubMed ID: 8878719
[TBL] [Abstract][Full Text] [Related]
20. Management of women with mild and moderate cervical dyskaryosis.
Flannelly G; Anderson D; Kitchener HC; Mann EM; Campbell M; Fisher P; Walker F; Templeton AA
BMJ; 1994 May; 308(6941):1399-403. PubMed ID: 8019248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]